-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On VolitionRX with Buy Rating, Announces Price Target of $2.5

Benzinga·04/08/2025 11:07:12
Listen to the news
HC Wainwright & Co. analyst Yi Chen initiates coverage on VolitionRX (AMEX:VNRX) with a Buy rating and announces Price Target of $2.5.